001     1043723
005     20250717202252.0
024 7 _ |a 10.1016/j.focha.2025.100969
|2 doi
024 7 _ |a 10.34734/FZJ-2025-03009
|2 datacite_doi
037 _ _ |a FZJ-2025-03009
082 _ _ |a 660
100 1 _ |a Olubiyi, Olujide Oludayo
|0 P:(DE-Juel1)138971
|b 0
|e Corresponding author
245 _ _ |a Novel dietary herbal preparations with inhibitory activities against multiple SARS-CoV-2 targets: A multidisciplinary investigation into antiviral activities
260 _ _ |a [Amsterdam]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1752742609_3508
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The outbreak of the COVID-19 pandemic has resulted in not <7.1million deaths globally as of December 2024. Many new variants of concern have continued to emerge since the initial outbreak of the original SARS-CoV-2 virus traceable to the Wuhan strain (Wuhan-Hu-1). In this work, the therapeutic potentials of four new polyherbal dietary preparations – VIVE (five plants), FORTE1(fortified VIVE), COMBI-5 (five spices) and MOK (Moringa seed) as well as four individual ethnomedicinal plants were investigated. Computational screening revealed chemical structures capable of establishing moderate to strong interaction with SARS-CoV-2′s main protease enzyme, while in vitro screening against the viral protease clearly established inhibitory potencies. The individual plant extracts making up VIVE and FORTE1 showed mild (494.9 ± 19.6 µg/ml) to moderate (21.5 ± 1.1 µg/ml) inhibitory activity against the viral enzyme in vitro; highest activity was obtained in the polyherbal VIVE preparation (17.3 ± 1.4 µg/ml). The MOK exerted total inhibition – 100 % (IC50 -3.6 ± 0.9) of the viral enzyme while COMBI-5 produced an inhibition of 95 %(IC50 - 0.9 ± 0.1). These results revealed the potential of specialized metabolites within these widely consumed dietary herbal products for the management of COVID-19 and related viral threats.
536 _ _ |a 5241 - Molecular Information Processing in Cellular Systems (POF4-524)
|0 G:(DE-HGF)POF4-5241
|c POF4-524
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Attah, Francis Alfred
|0 0000-0003-0787-0204
|b 1
700 1 _ |a Strodel, Birgit
|0 P:(DE-Juel1)132024
|b 2
|u fzj
700 1 _ |a Eberle, Raphael Josef
|0 P:(DE-Juel1)179561
|b 3
700 1 _ |a Coronado, Monika Aparecida
|b 4
700 1 _ |a Akinseinde, Oluwadotun
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Onyeaghala, Augustine Anayochukwu
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Uzochukwu, Ikemefuna Chijioke
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Kotila, Olayinka Adejoke
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Dada-Adegbola, Hannah
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Adepiti, Awodayo Oluwatoyin
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Elujoba, Anthony Adebolu
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Babalola, Chinedum Peace
|0 P:(DE-HGF)0
|b 12
|e Corresponding author
773 _ _ |a 10.1016/j.focha.2025.100969
|g Vol. 7, p. 100969 -
|0 PERI:(DE-600)3116248-4
|p 100969 -
|t Food chemistry advances
|v 7
|y 2025
|x 2772-753X
856 4 _ |u https://juser.fz-juelich.de/record/1043723/files/1-s2.0-S2772753X25000851-main.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:1043723
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)132024
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-524
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Molecular and Cellular Information Processing
|9 G:(DE-HGF)POF4-5241
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-05
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-04-11T11:05:44Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-04-11T11:05:44Z
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2022-04-11T11:05:44Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-05
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-05
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21